Patient Guide: Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 136 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04162210
Status: ACTIVE_NOT_RECRUITING
Condition: Multiple Myeloma
Phase: PHASE3

Find a Study Location Near You

This study is available at 136 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Tucson, Arizona
  • Pueblo, Colorado
  • Detroit, Michigan
  • • And 133 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily